Audience
With an impact factor of 13.054 (SCI Journals Citation Reports 2004), Trends in Pharmacological Sciences keeps pharmacology students and teachers, research scientists, professors and directors up to date with the latest developments in pharmacology and toxicology.
Instructions to Authors
Trends in Pharmacological Sciences is now review only, and is divided into three main sections: Update, Opinion and Review. Articles for Trends in Pharmacological Sciences are usually commissioned by the Editor, but proposals for articles are welcome, especially for the Update section. Prospective authors should send a brief summary, citing key references, to the Editor, who will supply guidelines on manuscript preparation if the proposal is accepted. The submission of completed manuscripts without prior consultation with the Editor is strongly discouraged. Authors should note that all major articles in Trends in Pharmacological Sciences are peer-reviewed and publication cannot be guaranteed.
Review and Opinion articles form the foundation of each monthly issue. Reviews are invited from leading researchers in a specific field and objectively chronicle recent and important developments in newly emerging or rapidly progressing fields. Principles are a sub-category of the Review section and provide a forum for the discussion of conceptual and theoretical thinking on specific aspects of pharmacology. Techniques articles form another sub-category of the Review section and discuss groundbreaking technical advances. Opinion articles present a personal, authoritative viewpoint of a field or research-related subject. They can cover timely controversial topics or debates, provide a new framework for, or interpretation of, an old problem or current issue, or speculate in depth on the implications of some recently published research or data.
The Update section includes Research Focus articles and Letters to the Editor. Research Focus articles highlight topical issues and recent research papers of particular note, explaining their significance for a wide audience. The decision to publish Letters rests with the Editor, and the author(s) of any article discussed in a Letter will normally be invited to reply. Letters can address topics raised in recent issues of the journal, or other matters of general interest to pharmacologists and toxicologists. Letters should be no more than 700 words long with a maximum of 10 references and one figure. An electronic version of the text should be e-mailed to: tips@elsevier.com (or post a hardcopy plus an electronic copy on disc to the journal address).
The Editor
Trends in Pharmacological Sciences
Elsevier
32 Jamestown Road
London
UK, NW1 7BY
Editorial Board
S.G. Amara, Portland, OR, USA
H. Betz, Frankfurt, Germany
N.J.M. Birdsall, London, UK
N.G. Bowery, Birmingham, UK
J.N. Crawley, Bethesda, MD, USA
A.C. Cuello, Montréal, Canada
A. Dray, Montreal, Canada
J.R. Fozard, Basel, Switzerland
B.B. Fredholm, Stockholm, Sweden
T.P. Kenakin, Research Triangle Park, NC, USA
R.W. Kerwin, London, UK
B.K. Kobilka, Stanford, CA, UK
M. Lazdunski, Valbonne, France
G-Q. Liu, Nanjing, China
C.A. Maggi, Florence, Italy
J. Meldolesi, Milan, Italy
M. Mishina, Tokyo, Japan
W.H. Moolenaar, Amsterdam, The Netherlands
C.P. Page, London, UK
R. Ruffolo, Jr, King of Prussia, PA, USA
T.K. Sawyer, Cambridge, MA, USA
R.J. Summers, Melbourne, Australia
T. Tanaka, Tsu, Japan
D. Wallach, Rehovot, Israel
Z.G. Wang, Beijing, China
S.P. Watson, Birmingham, UK
Abstracting/Indexing
CAB Abstracts International
Chemical Abstracts
Current Contents (Life Science)
Index Medicus
Medline/MEDLARS Online
Nucleic Acids Abstracts
Reference Update
Science Citation Index
SciSearch/Science Citation Index Expanded
Bibliographic Information
Commenced publication 1979
Volume 29
2008, 12 issues
ISSN: 0165-6147
Statement on publishing ethics
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct.
Conflict of Interest Policy
The
Publisher now requires authors to declare any conflicts of interest that relate
to papers accepted for publication in this Journal. A conflict of interest may
exist when an author or the author's institution has a financial or other
relationship with other people or organizations that may inappropriately
influence the author’s work. A conflict can be actual or potential and full
disclosure to the Journal is the safest course. All submissions to the Journal
must include disclosure of all relationships that could be viewed as presenting
a potential conflict of interest. The Journal may use such information as a
basis for editorial decisions and may publish such disclosures if they are
believed to be important to readers in judging the manuscript. A decision may be
made by the Journal not to publish on the basis of the declared conflict. For
more information, please refer to:
http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest
Copyright statement
© 2008 Elsevier Ltd. All rights reserved.
This journal and the individual contributions contained in it are protected
under copyright by Elsevier Ltd., and the following terms and conditions
apply to their use:
Photocopying
Single photocopies
of single articles may be made for personal use as allowed by national
copyright laws. Permission of the publisher and payment of a fee is required
for all other photocopying, including multiple or systematic copying,
copying for advertising or promotional purposes, resale, and all forms
of document delivery. Special rates are available for educational institutions
that wish to make photocopies for non-profit educational classroom use.
Elsevier
Science Rights & Permissions Department
PO Box 800
Oxford
UK OX5 1DX
Tel:+44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: permissions@elsevier.co.uk
You may also contact Global Rights directly through Elsevier's home page (http://www.elsevier.com), selecting first 'Customer Support', then 'Permissions', then 'Permissions Request Form'.
In the USA, users
may clear permissions and make payments through the
Copyright Clearance Center Inc
222 Rosewood Drive
Danvers
MA 01923, USA
Tel: +1 (978) 750 8400
Fax: +1 (978) 750 4744
and in the UK through the
Copyright Licensing
Agency Rapid Clearance Service (CLARCS)
90 Tottenham Court Road
London, UK W1P 0LP
Tel: +44 (0)
20 7631 5555
Fax: +44 (0)
20 7436 5500
Other countries may have a local reprographic rights agency for payments.
Derivative Works
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for
internal circulation within their institutions. Permission of the publisher
is required for resale or distribution outside the institution.
Permission of the publisher is required for all other derivative works,
including compilations and translations.
Electronic Storage or Usage
Permission of the publisher is required to store or use electronically
any material contained in this journal, including any article or part
of an article. Contact the publisher at the address indicated. Except
as outlined above, no part of this publication may be reproduced, stored
in a retrieval system or transmitted in any form or by any means, electronic,
mechanical, photocopying, recording or otherwise, without prior written
permission of the publisher. Address permissions requests to: Elsevier
Science Rights & Permissions Department, at the mail, fax and e-mail addresses
noted above.
Notice
No responsibility is
assumed by the Publisher for any injury and/or damage to persons or property
as a matter of products liability, negligence or otherwise, or from any
use or operation of any methods, products, instructions or ideas contained
in the material herein. Because of rapid advances in the medical sciences,
in particular, independent verification of diagnoses and drug dosages
should be made.
Although all advertising material is expected to conform to ethical (medical)
standards, inclusion in this publication does not constitute a guarantee
or endorsement of the quality or value of such product or of the claims
made of it by its manufacturer.